# Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/metabolic-benefits-24-months-after-replacing-a-protease-inhibitor-with-abacavir/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cesar Fisac,Emilio Fumero,Manuel Crespo,Beatriz Rosón,Elena Ferrer,N. Virgili,Esteban Ribera,José María Gatell,Daniel Podzamczer |
| Citations | 116 |
| DOI | 10.1097/01.aids.0000171405.46113.bf |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1999791725 |
| PMID | 15905672 |
| Type | article |
| Year | 2005 |

## Paper authors

- [N. Virgili](https://scholariq.org/researchers/n-virgili/)

## Paper primary topic

- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)

## Paper topics

- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Biological Research and Disease Studies](https://scholariq.org/topics/biological-research-and-disease-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.